These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35857584)

  • 1. SARS-CoV-2 epitope-specific CD4
    Nelson RW; Chen Y; Venezia OL; Majerus RM; Shin DS; ; Carrington MN; Yu XG; Wesemann DR; Moon JJ; Luster AD
    Sci Immunol; 2022 Jul; 7(73):eabl9464. PubMed ID: 35857584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breadth and Durability of SARS-CoV-2-Specific T Cell Responses following Long-Term Recovery from COVID-19.
    Dang TTT; Anzurez A; Nakayama-Hosoya K; Miki S; Yamashita K; de Souza M; Matano T; Kawana-Tachikawa A
    Microbiol Spectr; 2023 Aug; 11(4):e0214323. PubMed ID: 37428088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-reactive and mono-reactive SARS-CoV-2 CD4+ T cells in prepandemic and COVID-19 convalescent individuals.
    Johansson AM; Malhotra U; Kim YG; Gomez R; Krist MP; Wald A; Koelle DM; Kwok WW
    PLoS Pathog; 2021 Dec; 17(12):e1010203. PubMed ID: 34965282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2-specific circulating T follicular helper cells correlate with neutralizing antibodies and increase during early convalescence.
    Boppana S; Qin K; Files JK; Russell RM; Stoltz R; Bibollet-Ruche F; Bansal A; Erdmann N; Hahn BH; Goepfert PA
    PLoS Pathog; 2021 Jul; 17(7):e1009761. PubMed ID: 34270631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal Assessment of SARS-CoV-2-Specific T Cell Cytokine-Producing Responses for 1 Year Reveals Persistence of Multicytokine Proliferative Responses, with Greater Immunity Associated with Disease Severity.
    Lin J; Law R; Korosec CS; Zhou C; Koh WH; Ghaemi MS; Samaan P; Ooi HK; Matveev V; Yue F; Gingras AC; Estacio A; Buchholz M; Cheatley PL; Mohammadi A; Kaul R; Pavinski K; Mubareka S; McGeer AJ; Leis JA; Heffernan JM; Ostrowski M
    J Virol; 2022 Jul; 96(13):e0050922. PubMed ID: 35699447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of conserved SARS-CoV-2 spike epitopes that expand public cTfh clonotypes in mild COVID-19 patients.
    Lu X; Hosono Y; Nagae M; Ishizuka S; Ishikawa E; Motooka D; Ozaki Y; Sax N; Maeda Y; Kato Y; Morita T; Shinnakasu R; Inoue T; Onodera T; Matsumura T; Shinkai M; Sato T; Nakamura S; Mori S; Kanda T; Nakayama EE; Shioda T; Kurosaki T; Takeda K; Kumanogoh A; Arase H; Nakagami H; Yamashita K; Takahashi Y; Yamasaki S
    J Exp Med; 2021 Dec; 218(12):. PubMed ID: 34647971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment and recall of SARS-CoV-2 spike epitope-specific CD4
    Wragg KM; Lee WS; Koutsakos M; Tan HX; Amarasena T; Reynaldi A; Gare G; Konstandopoulos P; Field KR; Esterbauer R; Kent HE; Davenport MP; Wheatley AK; Kent SJ; Juno JA
    Nat Immunol; 2022 May; 23(5):768-780. PubMed ID: 35314848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limited Recognition of Highly Conserved Regions of SARS-CoV-2.
    Swaminathan S; Lineburg KE; Ambalathingal GR; Crooks P; Grant EJ; Mohan SV; Raju J; Panikkar A; Le Texier L; Tong ZWM; Chew KY; Neller MA; Short KR; Gowda H; Gras S; Khanna R; Smith C
    Microbiol Spectr; 2022 Feb; 10(1):e0278021. PubMed ID: 35196796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term, CD4
    Wirsching S; Harder L; Heymanns M; Gröndahl B; Hilbert K; Kowalzik F; Meyer C; Gehring S
    Front Immunol; 2022; 13():800070. PubMed ID: 35514974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
    Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
    Front Immunol; 2021; 12():802858. PubMed ID: 35003131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal immune profiling reveals dominant epitopes mediating long-term humoral immunity in COVID-19-convalescent individuals.
    Li M; Liu J; Lu R; Zhang Y; Du M; Xing M; Wu Z; Kong X; Zhu Y; Zhou X; Hu L; Zhang C; Zhou D; Jin X
    J Allergy Clin Immunol; 2022 Apr; 149(4):1225-1241. PubMed ID: 35074422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of mouse CD4
    Bricio-Moreno L; Barreto de Albuquerque J; Neary JM; Nguyen T; Kuhn LF; Yeung Y; Hastie KM; Landeras-Bueno S; Olmedillas E; Hariharan C; Nathan A; Getz MA; Gayton AC; Khatri A; Gaiha GD; Ollmann Saphire E; Luster AD; Moon JJ
    Front Immunol; 2024; 15():1329846. PubMed ID: 38529279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2-specific T cell memory with common TCRαβ motifs is established in unvaccinated children who seroconvert after infection.
    Rowntree LC; Nguyen THO; Kedzierski L; Neeland MR; Petersen J; Crawford JC; Allen LF; Clemens EB; Chua B; McQuilten HA; Minervina AA; Pogorelyy MV; Chaurasia P; Tan HX; Wheatley AK; Jia X; Amanat F; Krammer F; Allen EK; Sonda S; Flanagan KL; Jumarang J; Pannaraj PS; Licciardi PV; Kent SJ; Bond KA; Williamson DA; Rossjohn J; Thomas PG; Tosif S; Crawford NW; van de Sandt CE; Kedzierska K
    Immunity; 2022 Jul; 55(7):1299-1315.e4. PubMed ID: 35750048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Memory B cells targeting SARS-CoV-2 spike protein and their dependence on CD4
    Pušnik J; Richter E; Schulte B; Dolscheid-Pommerich R; Bode C; Putensen C; Hartmann G; Alter G; Streeck H
    Cell Rep; 2021 Jun; 35(13):109320. PubMed ID: 34146478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal Analysis of Human Memory T-Cell Response According to the Severity of Illness up to 8 Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    Kang CK; Kim M; Lee S; Kim G; Choe PG; Park WB; Kim NJ; Lee CH; Kim IS; Jung K; Lee DS; Shin HM; Kim HR; Oh MD
    J Infect Dis; 2021 Jul; 224(1):39-48. PubMed ID: 33755725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Durability of SARS-CoV-2-Specific T-Cell Responses at 12 Months Postinfection.
    Lu Z; Laing ED; Pena DaMata J; Pohida K; Tso MS; Samuels EC; Epsi NJ; Dorjbal B; Lake C; Richard SA; Maves RC; Lindholm DA; Rozman JS; English C; Huprikar N; Mende K; Colombo RE; Colombo CJ; Broder CC; Ganesan A; Lanteri CA; Agan BK; Tribble D; Simons MP; Dalgard CL; Blair PW; Chenoweth J; Pollett SD; Snow AL; Burgess TH; Malloy AMW;
    J Infect Dis; 2021 Dec; 224(12):2010-2019. PubMed ID: 34673956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spike-specific circulating T follicular helper cell and cross-neutralizing antibody responses in COVID-19-convalescent individuals.
    Zhang J; Wu Q; Liu Z; Wang Q; Wu J; Hu Y; Bai T; Xie T; Huang M; Wu T; Peng D; Huang W; Jin K; Niu L; Guo W; Luo D; Lei D; Wu Z; Li G; Huang R; Lin Y; Xie X; He S; Deng Y; Liu J; Li W; Lu Z; Chen H; Zeng T; Luo Q; Li YP; Wang Y; Liu W; Qu X
    Nat Microbiol; 2021 Jan; 6(1):51-58. PubMed ID: 33199863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of IFNγ-Secreting CD4
    Matyushenko V; Isakova-Sivak I; Kudryavtsev I; Goshina A; Chistyakova A; Stepanova E; Prokopenko P; Sychev I; Rudenko L
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4
    Meckiff BJ; Ramírez-Suástegui C; Fajardo V; Chee SJ; Kusnadi A; Simon H; Eschweiler S; Grifoni A; Pelosi E; Weiskopf D; Sette A; Ay F; Seumois G; Ottensmeier CH; Vijayanand P
    Cell; 2020 Nov; 183(5):1340-1353.e16. PubMed ID: 33096020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 coronavirus vaccine T cell epitope prediction analysis based on distributions of HLA class I loci (HLA-A, -B, -C) across global populations.
    Cun Y; Li C; Shi L; Sun M; Dai S; Sun L; Shi L; Yao Y
    Hum Vaccin Immunother; 2021 Apr; 17(4):1097-1108. PubMed ID: 33175614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.